Abstract：Objective To explore the correlation of peripheral blood cells changes and serum lactate dehydrogenase levels in patients with hepatitis cirrhosis, in order to detect early pathological bone marrow hematopoietic and to provide evidence for early diagnosis and treatment and prognosis.Method The hemoglobin, neutrophile, platelet, granulofilocyte,serum alanine aminotransferase (ALT) as well as serum lactic dehydrogenase (LDH) activity of Peripheral Blood (PB) from 227 hepatitis hepatocirrhosis patients and 50 health controls were analyzed.Relults The LDH levels of hepatitis, cirrhosis patients had negatively correlation with peripheral blood three-line cytopenia (r=-0.789,P<0.05), and positively correlated with increased reticulocyte (r=0.576,P<0.05), significantly associated with poor prognosis(r=0.778,P<0.05). Conclusion Hepatitis, liver cirrhosis patients with elevated serum LDH can be used as Objective indicators of early pathological hematopoietic, and the evidence for early prevention and treatment and prognosis.
景晔, 陈银海, 徐和福, 杨辉, 王莉. 肝炎肝硬化外周血细胞变化与乳酸脱氢酶的相关性分析[J]. 解放军预防医学杂志, 2016, 34(3): 379-381.
JING Ye, CHEN Yinhai, XU Hefu, YANG Hui, WANG Li. Correlation of the Peripheral Blood Cells Changes and Lactate Dehydrogenase Levels in Hepatitis and Cirrhosis. Journal of Preventive Medicine of Chinese People's Liberation Army, 2016, 34(3): 379-381.
〔1〕 周英杰.贫血科学防治新理念〔M〕北京:金盾出版社,2012:212. 〔2〕 邓家栋 主编.临床血液学〔M〕.上海:上海科学技术出版社,1985:485. 〔3〕 陈菊梅 主编.现代传染病学〔M〕.北京:人民军医出版社,1999:286. 〔4〕 李雪峰.血清5项指标联合检测对原发性肝癌的诊断探讨〔J〕.检验医学与临床,2012,9(5):569. 〔5〕 刘人伟.检验与临床〔M〕.北京:化学工业出版社,2009:119. 〔6〕 丛玉隆,尹一兵,陈瑜,等.检验医学高等教程〔M〕.北京:人民军医出版社,2010:474. 〔7〕 ESKILDSEN-HELMOND Y E,VAN HEUGTEN H A,LAMERS J M. Regulation and functional significance of phospholipase D in myocardium 〔J〕.Mol Cell Biochem, 1996,157(1):39. 〔8〕 LIU X H.Preconditioning:a general biological phenomenon and its mechanism 〔J〕.Sheng Li Ke Xue Jin Zhan,1998,29(1):39. 〔9〕 王向杰,刘丽,刘键,等.促红细胞生成素对慢性肾衰竭贫血患者骨髓祖细胞的影响〔J〕.解放军医药杂志,2012,24(4):39. 〔10〕 陆光生,景晔,徐和福,等.肝炎肝硬化患者血常规和骨髓祖细胞造血功能的改变〔J〕.解放军预防医学杂志,2013,31(5):421. 〔11〕 景晔,徐和福,陆光生,等,肝炎肝硬化骨髓超微结构改变的临床意义〔J〕.解放军预防医学杂志,2014,32(4):330. 〔12〕 钱超,余建华,吴文静,等.乙型肝炎肝硬化患者红细胞参数及相关细胞因子检测分析〔J〕.检验医学与临床,2013,10(5):526. 〔13〕 杨继红.肝硬化患者血小板参数的变化及其临床意义〔J〕.检验医学与临床,2013,10(8):994. 〔14〕 LLOVET J M,LOK A.Hepatitis B virus genotype and mutants:risk factors for hepatocellular carcinoma〔J〕.J Natl Cancer Inst,2008,100(16):1121. 〔15〕 王建芳,郁金红,赵磊,等.肝硬化腹水患者血清与腹水中LDH、ADA、SAAG、联合检测的临床意义〔J〕.检验医学与临床,2013(A01):45. 〔16〕 YANG L,HAN G H.Revising consensus in port of the Baveno Vconsessus Workshop〔J〕.J Clinic Hepatol,2011,27(2):116. 〔17〕 HUBER A,EBNER L,MONTANI M,et al.Computed tomography findings in liver fibrosis and cirrhosis〔J〕.Swiss Med Wkly,2014,144:13923. 〔18〕 吕云福,李新秋,黄伟炜,等.门静脉高压性脾功能亢进患者的外周血细胞变化〔J〕.中华普通外科杂志,2007,22(9):702. 〔19〕 KARASU Z,GURAKAR A,KERWIN B,et al.Effect of transjuqular intrahepatic portosystemic shunt on thrombocytopenia associated with cirrhosis〔J〕.Dig Dis Sci,2001,46(2):499. 〔20〕 YAN F,LI W,GAO J,et al.DN A micoarray-based screening of differentially expressed genes in macrophages in the spleen of patients with portal hypertension and hypersplenism〔J〕.Nan Fang Yi Ke Da Xue Bao,2006,26(11):1548.
2016, Vol. 34 
